Enzyre

Enzyre BV Aims to Develop an Innovative Near-Patient Testing (NPT) Device Called Enzypad to Measure Biomarkers in Body Fluids. The First Application of Enzypad Will Monitor Hemophilia by Providing a Real-Time Picture of the Patient’s Blood Coagulation Status. Results from Each Test Will Be Automatically Sent to the Treating Doctor via an App on the Patient's Mobile Phone.